Filing Details
- Accession Number:
- 0001209191-23-035862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-09 16:26:47
- Reporting Period:
- 2023-06-07
- Accepted Time:
- 2023-06-09 16:26:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501756 | Adverum Biotechnologies Inc. | ADVM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1321937 | M Linda Rubinstein | C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-07 | 100,000 | $1.45 | 100,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.